{
    "code": "02019191",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019191",
    "time": "2016-11-18 19:38:24",
    "許可證字號": "衛署藥輸字第019191號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/07\/13",
    "發證日期": "102\/05\/02",
    "許可證種類": "製　劑",
    "舊證字號": "02004431",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201919102",
    "中文品名": "撲類惡注射劑",
    "英文品名": "BLEOCIN FOR INJECTION 5MG",
    "適應症": "皮膚癌及頭頸部癌（上顎癌、舌癌、口唇癌、咽頭癌、口腔癌）、肺癌（原發性及轉移性扁平上皮癌）、食道癌、惡性淋巴腫",
    "劑型": "270注射劑",
    "包裝": "1-100安瓿 1-100玻璃瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "BLEOMYCINHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1435301100  臺灣日化股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260224100  NIPPON KAYAKU CO.,LTD.",
        "製造廠廠址": "239, IWAHANAMACHI, TAKASAKI-SHI, GUNMA370-1208 JAPAN",
        "製造廠公司地址": "1-1, MARUNOUCHI 2-CHOME, CHIYODA-KU, TOKYO 100-0005, JAPAN",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000210",
            "成分名稱": "BLEOMYCIN HCL",
            "含量描述": "(POTENCY)",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "BLEOCIN PI (Final version)___20130410.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02019191&Seq=001&Type=9"
        },
        {
            "title": "P1013572___20130410.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02019191&Seq=002&Type=8"
        },
        {
            "title": "P1013527___20130410.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02019191&Seq=001&Type=8"
        }
    ]
}